WallStreetZenWallStreetZen

NASDAQ: LSTA
Lisata Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LSTA

Based on 1 analyst offering 12 month price targets for Lisata Therapeutics Inc.
Min Forecast
$15.00+383.87%
Avg Forecast
$15.00+383.87%
Max Forecast
$15.00+383.87%

Should I buy or sell LSTA stock?

Based on 1 analyst offering ratings for Lisata Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LSTA stock forecasts and price targets.

LSTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-13

1 of 1

Forecast return on equity

Is LSTA forecast to generate an efficient return?
Company
-36.54%
Industry
-388.81%
Market
59.09%
LSTA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LSTA forecast to generate an efficient return on assets?
Company
-32.83%
Industry
27.33%
LSTA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LSTA earnings per share forecast

What is LSTA's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$2.97
Avg 2 year Forecast
-$2.17
Avg 3 year Forecast
-$1.58

LSTA revenue forecast

What is LSTA's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$7.2M

LSTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LSTA$3.10$15.00+383.87%Buy
SABS$2.84$12.75+348.94%Strong Buy
ENLV$1.27$9.50+648.03%Strong Buy
MRKR$2.98$11.00+269.13%Strong Buy
HCWB$0.70N/AN/A
View Top Biotech Stocks

Lisata Therapeutics Stock Forecast FAQ

Is Lisata Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: LSTA) stock is to Buy LSTA stock.

Out of 1 analyst, 0 (0%) are recommending LSTA as a Strong Buy, 1 (100%) are recommending LSTA as a Buy, 0 (0%) are recommending LSTA as a Hold, 0 (0%) are recommending LSTA as a Sell, and 0 (0%) are recommending LSTA as a Strong Sell.

If you're new to stock investing, here's how to buy Lisata Therapeutics stock.

What is LSTA's earnings growth forecast for 2024-2026?

(NASDAQ: LSTA) Lisata Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.02%.

Lisata Therapeutics's earnings in 2024 is -$21,071,000.On average, 2 Wall Street analysts forecast LSTA's earnings for 2024 to be -$24,709,212, with the lowest LSTA earnings forecast at -$24,875,604, and the highest LSTA earnings forecast at -$24,542,820. On average, 1 Wall Street analyst forecast LSTA's earnings for 2025 to be -$18,053,532, with the lowest LSTA earnings forecast at -$18,053,532, and the highest LSTA earnings forecast at -$18,053,532.

In 2026, LSTA is forecast to generate -$13,144,968 in earnings, with the lowest earnings forecast at -$13,144,968 and the highest earnings forecast at -$13,144,968.

What is LSTA's revenue growth forecast for 2028-2028?

(NASDAQ: LSTA) Lisata Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.98%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.26%.

Lisata Therapeutics's revenue in 2024 is $0.

In 2028, LSTA is forecast to generate $59,901,120 in revenue, with the lowest revenue forecast at $59,901,120 and the highest revenue forecast at $59,901,120.

What is LSTA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: LSTA) forecast ROA is -32.83%, which is lower than the forecast US Biotechnology industry average of 27.33%.

What is LSTA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year LSTA price target, the average LSTA price target is $15.00, with the highest LSTA stock price forecast at $15.00 and the lowest LSTA stock price forecast at $15.00.

The Wall Street analyst predicted that Lisata Therapeutics's share price could reach $15.00 by Aug 13, 2025. The average Lisata Therapeutics stock price prediction forecasts a potential upside of 383.87% from the current LSTA share price of $3.10.

What is LSTA's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: LSTA) Lisata Therapeutics's current Earnings Per Share (EPS) is -$2.57. On average, analysts forecast that LSTA's EPS will be -$2.97 for 2024, with the lowest EPS forecast at -$2.99, and the highest EPS forecast at -$2.95. On average, analysts forecast that LSTA's EPS will be -$2.17 for 2025, with the lowest EPS forecast at -$2.17, and the highest EPS forecast at -$2.17. In 2026, LSTA's EPS is forecast to hit -$1.58 (min: -$1.58, max: -$1.58).

What is LSTA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: LSTA) forecast ROE is -36.54%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.